Lam Research (NASDAQ:LRCX) Price Target Raised to $300.00

Lam Research (NASDAQ:LRCX) had its price objective boosted by JPMorgan Chase & Co. from $165.00 to $300.00 in a research report sent to investors on Thursday morning,Benzinga reports. They currently have an overweight rating on the semiconductor company’s stock.

LRCX has been the topic of a number of other research reports. Dbs Bank upped their target price on shares of Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Morgan Stanley set a $211.00 target price on shares of Lam Research in a report on Thursday, January 15th. Bank of America lifted their price target on shares of Lam Research from $195.00 to $245.00 and gave the company a “buy” rating in a report on Tuesday, January 13th. Wells Fargo & Company raised their target price on shares of Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Berenberg Bank upped their target price on Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $238.32.

Lam Research Stock Performance

Shares of LRCX stock opened at $233.46 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.60. Lam Research has a 12 month low of $56.32 and a 12 month high of $251.87. The company’s fifty day moving average price is $187.29 and its two-hundred day moving average price is $146.33. The firm has a market capitalization of $293.23 billion, a P/E ratio of 47.84, a P/E/G ratio of 3.05 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.Lam Research’s quarterly revenue was up 22.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, research analysts anticipate that Lam Research will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd were given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Wednesday, December 3rd. Lam Research’s payout ratio is 21.31%.

Insider Buying and Selling at Lam Research

In related news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 41,408 shares of company stock valued at $6,248,501. Company insiders own 0.31% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in LRCX. PMV Capital Advisers LLC acquired a new stake in Lam Research in the fourth quarter worth approximately $25,000. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the 2nd quarter worth $26,000. Stance Capital LLC acquired a new stake in shares of Lam Research in the third quarter valued at $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter valued at $27,000. Finally, Triumph Capital Management bought a new position in Lam Research during the third quarter valued at about $27,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple major brokers sharply raised targets (many to $275–$300), signaling broad analyst bullishness after the quarter and suggesting upside versus earlier prices. These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results
• Positive Sentiment: JPMorgan and Citigroup raised targets to $300 (overweight/buy), and firms including Needham, TD Cowen, Wells Fargo, Deutsche and Stifel also lifted targets — a strong institutional vote of confidence for continued AI/foundry-driven demand. Analyst target increases (Benzinga)
• Positive Sentiment: Lam beat Q2 estimates (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B) and issued Q3 EPS guidance of $1.25–$1.45 and revenue above consensus — concrete operational drivers behind analyst upgrades. Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
• Neutral Sentiment: New Street Research raised its target to $235 but kept a neutral rating, reflecting near-term upside limited relative to recent price strength. New Street adjusts price target on Lam Research to $235
• Negative Sentiment: HSBC raised its target to $221 but maintained a “hold,” which implies downside from recent levels and highlights some analyst caution despite better results. HSBC adjusts price target on Lam Research to $221
• Negative Sentiment: Coverage notes flag valuation concerns after a large run (high P/E and steep analyst target dispersion), which may limit further upside and explains some profit‑taking. Lam Research Earnings Beat Highlights AI Demand But Raises Valuation Questions

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.